|
Mar 22
|
Novo Nordisk (NVO) Gets Positive CHMP Opinion for Insulin Icodec
|
|
Mar 22
|
Merck's (MRK) Keytruda-Lynparza Combo Fails 2nd Lung Cancer Study
|
|
Mar 22
|
Zacks.com featured highlights QuickLogic, Willdan, Betterware, Modine Manufacturing and ADMA Biologics
|
|
Mar 21
|
Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal
|
|
Mar 21
|
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
|
|
Mar 21
|
ACELYRIN (SLRN) Up on Data From Thyroid Eye Disease Study
|
|
Mar 21
|
Spruce Biosciences (SPRB) Falls 86% in a Month: Here's Why
|
|
Mar 21
|
5 Stocks With Recent Price Strength With More Upside Left
|
|
Mar 21
|
Bristol Myers (BMY) Gets EC Nod for Abecma's Label Expansion
|
|
Mar 20
|
PTC Therapeutics (PTCT) Up on Positive Regulatory Updates
|
|
Mar 20
|
Axsome (AXSM) Begins Dosing in Depression Study on Sunosi
|
|
Mar 20
|
GSK Outperforms Industry on Strength in Key Drugs & Vaccines
|
|
Mar 20
|
Recent Price Trend in ADMA Biologics (ADMA) is Your Friend, Here's Why
|
|
Mar 19
|
AstraZeneca (AZN) Follows Boehringer, to Cap Inhaler Cost in US
|
|
Mar 19
|
Intellia (NTLA) Begins Dosing in Phase III ATTR Amyloidosis Study
|
|
Mar 18
|
Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up
|
|
Mar 18
|
Immuneering (IMRX) Plummets 71% in One Week: Here's Why
|
|
Mar 18
|
Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 33.56%: Read This Before Placing a Bet
|
|
Mar 18
|
Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest?
|
|
Mar 18
|
J&J (JNJ) Gets FDA Panel Vote for Carvykti's Expanded Use
|